Please assess the completion status of the following clinical trial:

Trial Title: NESP Pediatric Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 1 to 18 years of age~* ESRD receiving dialysis or CRI with eGFR less than 30 mL/min~* Baseline hemoglobin 9.5 - 12.5 g/dL and iron replete~* Stable rHuEPO therapy for 8 weeks~Exclusion Criteria:~* Scheduled for a living-related kidney transplant~* Uncontrolled blood pressure~* seizure activity~* Hyperparathyroidism~* Major surgery within 12 weeks or active inflammatory disease~* Currently receiving antibiotics~* Clinical evidence of malignancy~* Pregnant or breast-feeding

- Gender: None
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- rHuEPO (Type: ACTIVE_COMPARATOR): None
- darbepoetin alfa (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).